Cliff Asness’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
Cliff Asness's BDTX Position: Q3 2026 in Review
Cliff Asness opened a new position in Black Diamond Therapeutics (BDTX) in Q3 2026: 889,633 shares worth $1.68M. The stake represents ﹤0.01% of the portfolio and ranks #2770 among its holdings. This is a return to the name: Cliff Asness previously reported a position in BDTX as recently as Q3 2025.
Cliff Asness first reported a position in BDTX in Q1 2022 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.
- Cliff Asness held 889,633 shares of Black Diamond Therapeutics worth $1.68M as of Q3 2026.
- Black Diamond Therapeutics was a new Cliff Asness position in Q3 2026.
- Black Diamond Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #2770 holding.
- Cliff Asness first reported a position in Black Diamond Therapeutics in Q1 2022 and has held it in 7 quarters since.
- 110 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.